Hon. Janice M. Symchych (Former) brings years of experience to every intellectual property matter. As deputy general counsel of litigation for a Fortune 200 company in the high-tech device industry, the Judge managed a worldwide docket of intellectual property litigation. Behind the bench, she was known for her ability to quickly grasp these highly complex matters.
- Personally negotiated intellectual property settlements with Fortune 100 competitors, including a series of contentious cases with a decade-long history, and a one-to-one negotiated global resolution of many outstanding cases with another major competitor
- Responsible for worldwide docket of intellectual property litigation in highly competitive high-tech device industry, as deputy general counsel of litigation for Fortune 200 company. Work included due diligence and decision-making with both outside counsel and C-suite executives on initiation of specific infringement suits; strategic, factual, and legal theory development with in-house staff and outside counsel. Prepared and obtained settlement authorities, and either oversaw or led settlement negotiations or mediations. Decision-making on whether to take appeals, development and execution of appellate strategy on multiple significant issues in Federal Circuit.
- Served as arbitrator, both individually and as member of a tripartite panel, in intellectual property matters involving high-tech biomedical disputes
- Managed active pre-arbitration discovery and motions practice informed by years serving as United States Magistrate Judge
- Served as Court-appointed Trial Special Master with consent of parties in a public company's health care patent infringement case, with appeal to the Federal Circuit. Her findings of fact findings and conclusions of law were upheld on appeal
- Played oversight and collateral proceedings roles in significant international arbitrations involving insurance coverage disputes secondary to medical device recalls/class actions
- As outside counsel, litigated and ultimately resolved a complex intellectual property dispute between two Fortune 200 health care companies with civil RICO, criminal foreign espionage, and civil IP allegations. Case involved international conflicts of laws, potential corporate liabilities and individual liabilities of foreign nationals, as well as parallel federal grand jury proceedings.